Mirum Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $90,377 | $77,875 | $69,222 | $69,554 |
Gross Profit | 69,571 | 57,648 | 51,392 | 46,950 |
EBITDA | -4,247 | -14,580 | -15,414 | -26,377 |
EBIT | -10,302 | -20,434 | -21,078 | -31,776 |
Net Income | -14,235 | -24,638 | -25,279 | -33,149 |
Net Change In Cash | 90,377 | 77,875 | 69,222 | 69,554 |
Free Cash Flow | 13,803 | -14,582 | 15,199 | -21,617 |
Cash | 222,969 | 233,245 | 302,843 | 286,326 |
Basic Shares | 47,782 | 47,235 | 46,927 | 46,723 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $186,374 | $77,062 | $19,138 | $11,000 |
Gross Profit | 139,335 | 64,688 | 17,235 | -623 |
EBITDA | -136,490 | -122,411 | -65,386 | -102,306 |
EBIT | -147,319 | -126,092 | -66,361 | -102,929 |
Net Income | -163,415 | -135,665 | -83,988 | -103,270 |
Net Change In Cash | 186,374 | 77,062 | 19,138 | 11,000 |
Cost of Revenue | -3,349 | -10,745 | 130,087 | |
Free Cash Flow | -91,053 | -120,414 | -151,782 | -89,300 |
Cash | 286,326 | 28,003 | 31,340 | 142,086 |
Basic Shares | 40,885 | 33,839 | 30,321 | 25,251 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.29 |
2024-06-30 | -$0.52 |
2024-03-31 | -$0.54 |
2023-12-31 | -$0.66 |
